Navamedic ASA (FRA:N1A)
Germany · Delayed Price · Currency is EUR 1.845
+0.005 (0.27%)
At close: Jan 22, 2026
Navamedic ASA Income Statement
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 539.42 | 531.44 | 512 | 382.14 | 278.44 | 209.88 | |
Revenue Growth (YoY) | 2.64% | 3.80% | 33.98% | 37.24% | 32.67% | 11.19% |
Cost of Revenue | 341.45 | 325.92 | 313.63 | 218.62 | 166.7 | 139.54 |
Gross Profit | 197.97 | 205.52 | 198.37 | 163.52 | 111.74 | 70.34 |
Selling, General & Admin | 78.23 | 70.26 | 63.67 | 48.09 | 44.46 | 32.57 |
Amortization of Goodwill & Intangibles | 16.1 | 10.49 | 8.61 | 4.85 | 4.55 | 2.11 |
Other Operating Expenses | 88.7 | 88.7 | 83.13 | 63.75 | 49.12 | 39.03 |
Operating Expenses | 187.25 | 173.72 | 158.73 | 119.08 | 100.29 | 75.26 |
Operating Income | 10.72 | 31.8 | 39.64 | 44.45 | 11.46 | -4.93 |
Interest Expense | -19.56 | -10.01 | -7.77 | -0.61 | -2.5 | -2.71 |
Interest & Investment Income | 3.1 | 3.1 | 4.63 | 3.08 | 2.79 | 2.52 |
Earnings From Equity Investments | - | - | - | -1.1 | -3.19 | -4.53 |
Currency Exchange Gain (Loss) | -6.28 | -6.28 | 5.94 | -9.24 | -5.52 | -6.14 |
Other Non Operating Income (Expenses) | 6.91 | 6.91 | -6.43 | 13.58 | -0.68 | -0.81 |
EBT Excluding Unusual Items | -5.1 | 25.52 | 36.01 | 50.15 | 2.36 | -16.6 |
Merger & Restructuring Charges | -2.25 | - | -16.06 | - | - | - |
Gain (Loss) on Sale of Investments | -1.55 | -1.55 | -8.7 | -7.64 | - | - |
Other Unusual Items | -25.59 | -25.59 | -17.4 | - | - | - |
Pretax Income | -34.5 | -1.62 | -6.16 | 42.51 | 2.36 | -16.6 |
Income Tax Expense | 3.39 | 3.87 | 7.53 | 13.07 | 1.74 | -0.14 |
Earnings From Continuing Operations | -37.89 | -5.49 | -13.69 | 29.43 | 0.62 | -16.46 |
Net Income | -37.89 | -5.49 | -13.69 | 29.43 | 0.62 | -16.46 |
Net Income to Common | -37.89 | -5.49 | -13.69 | 29.43 | 0.62 | -16.46 |
Net Income Growth | - | - | - | 4662.46% | - | - |
Shares Outstanding (Basic) | - | 17 | 17 | 17 | 16 | 14 |
Shares Outstanding (Diluted) | - | 17 | 17 | 17 | 16 | 14 |
Shares Change (YoY) | - | 1.24% | 1.48% | 3.60% | 13.61% | 23.54% |
EPS (Basic) | - | -0.31 | -0.79 | 1.75 | 0.04 | -1.14 |
EPS (Diluted) | - | -0.31 | -0.79 | 1.73 | 0.04 | -1.14 |
EPS Growth | - | - | - | 4459.36% | - | - |
Free Cash Flow | -174.71 | 36.03 | -0.02 | 15.69 | -2.02 | -3.35 |
Free Cash Flow Per Share | - | 2.06 | -0.00 | 0.92 | -0.12 | -0.23 |
Gross Margin | 36.70% | 38.67% | 38.74% | 42.79% | 40.13% | 33.51% |
Operating Margin | 1.99% | 5.98% | 7.74% | 11.63% | 4.11% | -2.35% |
Profit Margin | -7.02% | -1.03% | -2.67% | 7.70% | 0.22% | -7.84% |
Free Cash Flow Margin | -32.39% | 6.78% | -0.00% | 4.11% | -0.73% | -1.60% |
EBITDA | 29.23 | 43.46 | 49.16 | 49.62 | 16.15 | -2.76 |
EBITDA Margin | 5.42% | 8.18% | 9.60% | 12.99% | 5.80% | -1.32% |
D&A For EBITDA | 18.51 | 11.66 | 9.52 | 5.18 | 4.69 | 2.16 |
EBIT | 10.72 | 31.8 | 39.64 | 44.45 | 11.46 | -4.93 |
EBIT Margin | 1.99% | 5.98% | 7.74% | 11.63% | 4.11% | -2.35% |
Effective Tax Rate | - | - | - | 30.76% | 73.79% | - |
Revenue as Reported | 531.44 | 531.44 | 512 | 382.14 | 278.44 | 209.88 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.